论文部分内容阅读
目的回顾性分析经外科病理检查证实的显著性和非显著性前列腺癌(PCa)的MRI、MRS与选定分子标记之间是否相互关联。方法本研究符合HIPAA,并得到机构审查委员会的批准,未获得知情同意书。选取89例经活检证实并在前列腺癌根治术前行直肠线圈MRI和MRS的男性病人(平均年龄63岁,范围46～79岁)。对可疑的临床不显著的前列腺癌采用0～3级回顾性、
Objective To retrospectively analyze MRI and MRS of significant and unremarkable prostate cancer (PCa) confirmed by surgical pathology whether they correlate with the selected molecular markers. Methods This study was in line with HIPAA and was approved by the Institutional Review Board without obtaining informed consent. A total of 89 male patients (mean age 63 years, range, 46-79 years) who underwent biopsy and had rectal coil MRI and MRS before radical prostatectomy were selected. The suspicious clinically insignificant prostate cancer using 0 to 3 retrospective,